Search for: "National By-products, Inc. v. the United States" Results 1641 - 1660 of 1,808
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
17 Dec 2011, 6:36 am by Schachtman
INS, 240 F.3d 642, 645 n.7 (7th Cir. 2001) (Nazi deportation); United States v. [read post]
1 Nov 2009, 7:00 pm
Shusta, the court stated that even participants in an informal “kick the can” game owed no additional duty to each other than to refrain from intentional or willful and wanton misconduct. [19]             Some courts have broadened the scope of liability for sports participants by imposing a duty of care for unforeseeable risks which players would clearly not endorse… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to… [read post]
1 Jan 2014, 2:24 pm by Marty Lederman
  The women who work for such churches thus are virtually the only women in the United States who will not be afforded this new national benefit, which I described in further detail in this post. [read post]
17 Oct 2011, 1:39 pm by FDABlog HPM
Koustas – We have previously reported (here, here, here, and here) on the court struggle in the United States District Court for the District of Columbia (“the Court”) between FDA and Regenerative Sciences, Inc. [read post]
3 Dec 2009, 2:18 am
The Case against Consolidation       United States antitrust law aims to eliminate transactions that threaten the competitive process. [read post]
22 Oct 2009, 2:59 pm
See, e.g., Lockheed Martin Corp. v. [read post]
5 Sep 2008, 11:01 pm
& Ors v Deisel Spa and Case C-302/08 Zino Davidoff SA v Bendesfinanzdirektion Sudost: (Class 46), EPO Boards of Appeal finds that when a fax is transmitted and an ‘OK’ is noted by the sender, this is evidence that the transmission was successful: (IPKat), Professor Hugenholtz slams European Commission for ignoring evidence on copyright extension: (Techdirt)   Germany Federal Patent Court publishes guidelines on colour trade mark Signal Yellow:… [read post]
9 Oct 2006, 5:12 pm
The Board found that the lead persons were required to manage their assigned teams, to correct improper performance, to shift employees, and to decide the order in which work was to be performed in order to achieve production goals. [read post]